Biohaven Ltd.

BHVN Healthcare Biotechnology

In the quarter to June 2026, EPS grew 53.1%, free cash flow grew 49.1% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

10.78 0.65 −5.69%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−49.0×
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
368.33 538.47 442.45 586.97 94.82 603.41 328.28 272.34 136.67 24.04
Total non-current assets
83.12 76.64 70.77 74.82 47.24 83.57 15.98 17.67 10.22 2.98
Total Assets
451.45 615.11 513.21 661.78 142.06 686.98 344.26 290.01 146.89 27.02
Total current liabilities
115.93 154.23 55.42 90.02 41.94 277.61 66.17 19.53 9.43 7.94
Total non-current liabilities
283.44 37.45 29.81 32.99 65.44 801.56 285.52 119.56 5.49 20.84
Total liabilities
399.38 191.67 85.24 123.01 107.37 1,079.16 351.69 139.09 14.92 28.78
Common Equity (Total)
52.07 423.44 427.98 538.77 34.69 (392.19) (7.42) 150.92 131.97 (45.03)
Shareholders Equity (Total)
52.07 423.44 427.98 538.77 34.69 (392.19) (7.42) 150.92 131.97 (1.76)
Total Debt
238.90 — — 30.58 2.80 267.46 248.00 118.00 — 0.60

Show all line items

In millions of $ except per-share values · columns are period end dates